Company signals · MedTech
Olympus Corporation
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: Against a Talent Market Index of 107.2 (Hot) (down 1.8 month-on-month), Americas is at rising (+10.6pts) on signal share.
Olympus Corporation: 1 signal in the last 90 days — in line with the MedTech median of 1 across 20 tracked companies.
Signals at Olympus Corporation
More signals across MedTech
Partnership · Americas
Sectra →Sectra deployed its Sectra One Cloud fully managed SaaS cloud enterprise imaging solution to Hennick Humber Hospital in Canada to improve radiology workflows and patient diagnostics.
Ma Activity · Americas
Medtronic →Medtronic completed acquisition of SPR Therapeutics for $650M cash. SPR specializes in FDA-cleared short-term peripheral nerve stimulation (PNS) therapy for chronic and acute pain. Deal adds SPRINT PNS System to Medtronic's neuromodulation portfolio.
Restructuring · Americas
Insulet Corporation →Manufacturing issues at Insulet's Acton facility led to medical device corrections affecting millions of insulin pump pods. SEC filings had previously claimed quality assurance inspections at various manufacturing steps, creating disclosure gap and triggering investor litigation.
Leadership Change · Americas
Illumina →Illumina appoints Daniel M. Skovronsky, Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, to its Board of Directors, effective June 16, 2026.
Capital Raising · Americas
Perimeter Medical Imaging AI, Inc. →Perimeter Medical Imaging AI filed Form D for private placement, indicating capital raising activity
Intelligence powered by Autonodal ↗